X0306 4 2023-01-27 0001531048 Inari Medical, Inc. NARI 0001806426 Tu Thomas C/O INARI MEDICAL, INC. 6001 OAK CANYON IRVINE CA 92618 1 Chief Medical Officer Common Stock 2023-01-27 4 M 0 10000 .457 A 95700 D Common Stock 2023-01-27 4 S 0 2699 58.32 D 93001 D Common Stock 2023-01-27 4 S 0 2130 59.88 D 90871 D Common Stock 2023-01-27 4 S 0 700 60.77 D 90171 D Common Stock 2023-01-27 4 S 0 3071 62.06 D 87100 D Common Stock 2023-01-27 4 S 0 1100 63.31 D 86000 D Common Stock 2023-01-27 4 S 0 300 63.94 D 85700 D Stock Option .457 2023-01-27 4 M 0 10000 0 D 2029-04-23 Common Stock 10000 149584 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022. This transaction was executed in multiple trades at prices ranging from $58.40 to $59.38 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $59.43 to $60.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $60.44 to $61.34 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $61.57 to $62.56 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $62.83 to $63.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $63.83 to $64.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The balance includes 264 shares acquired under the Company's Employee Stock Purchase Plan. The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter. /s/ Angela Ahmad, attorney-in-fact for Thomas Tu 2023-01-31